Literature DB >> 21185886

Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL/6 mice.

Akiko Muroyama1, Shota Kobayashi, Yasuhide Mitsumoto.   

Abstract

The molecular mechanisms underlying MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic (DAergic) neuronal death in vivo are still not fully understood. To investigate the selective DAergic neurotoxicity, we have developed an immunological technique to isolate DAergic synaptosomes from mouse striatal tissues using an antibody against 20 amino acid residues in the extracellular second loop of dopamine transporter (DAT). The DAT protein level in the isolated DAergic synaptosomes was markedly decreased at 16 h after a single injection of 30 mg/kg MPTP, but not in striatal homogenate and crude synaptosomes fraction. GBR-12909, a dopamine uptake inhibitor, completely reversed the MPTP-induced decrease of DAT protein in the DAergic synaptosomes. These results suggest that the isolated DAergic synaptosomes can be useful to identify mechanisms of loss of the nerve terminals.
Copyright © 2010 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185886     DOI: 10.1016/j.neures.2010.12.009

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  5 in total

Review 1.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

2.  Oral administration of coenzyme Q₁₀ reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice.

Authors:  Shota Kobayashi; Akiko Muroyama; Hiroaki Matsushima; Ikuo Yoshimura; Yasuhide Mitsumoto
Journal:  Neurol Sci       Date:  2011-05-20       Impact factor: 3.307

3.  Dopamine Synthesis as a Mechanism of Brain Plasticity in Nigrostriatal System Pathology.

Authors:  A A Kolacheva; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2018-05-19       Impact factor: 0.788

4.  COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism.

Authors:  Richard J Smeyne; Jeffrey B Eells; Debotri Chatterjee; Matthew Byrne; Shaw M Akula; Srinivas Sriramula; Dorcas P O'Rourke; Peter Schmidt
Journal:  Mov Disord       Date:  2022-06-09       Impact factor: 9.698

5.  Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.

Authors:  Lars Tönges; Tobias Frank; Lars Tatenhorst; Kim A Saal; Jan C Koch; Éva M Szego; Mathias Bähr; Jochen H Weishaupt; Paul Lingor
Journal:  Brain       Date:  2012-10-19       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.